ClinicalTrials.Veeva

Menu

Migraine STImulation Crisis of Migraine (MISTIC)

R

Remedee Labs

Status

Completed

Conditions

Migraine Without Aura

Treatments

Device: Wristband with millimeter wave emission.
Device: Placebo of wristband with millimeter wave emission.

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

Migraine is a neurovascular disease whose prevalence is estimated at almost 20% of the adult population. Currently, there is no treatment for migraine.

Millimeter stimulation of the wrist subcutaneous receptors allows the release of endorphin in the brain.

MISTIC is a prospective, controlled, multicenter, double-blind, randomized study in which the research team are investigating whether millimeter stimulation of subcutaneous wrist receptors reduces the frequency of migraine crisis.

Full description

MISTIC is a multicenter, controlled, randomized, double-blind study. Eligible patients will have to report their migraine crisis in a diary during a one month pre-selection phase. Then, patients will be randomized into one of two treatment groups :

  • active millimeter wave emission bracelet
  • or placebo bracelet

Patients will have to use the medical device twice a day for 3 months. The investigators will follow them for an additional 3 months to assess the persistence of the effect.

Throughout the follow-up, patients will report their migraines crisis in a journal.

The primary outcome will be the impact of wearing a millimeter wave bracelet for 3 months, on the number of days with migraine headaches.

Enrollment

140 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with episodic migraine without aura (according to ICDH3 classification criteria)
  • Patient with at leat 4 migraine days per month and no more than 8 migraine days per months
  • Background treatment (or not) stable for at least 1 month
  • Drug management of migraine stable for at least one month
  • Non-drug management of stable migraine at least 1 month prior to the study
  • Patient affiliated to social security or beneficiary of such a scheme

Exclusion criteria

  • Patients with chronic migraine (defined according to IHS criteria)
  • Patients already included in an interventional clinical research protocol
  • Patients with chronic headache due to drug abuse (according to IHS criteria)
  • Patients with only migraine crisis with aura
  • Wrist size < 14.5 and > 21 cm
  • Situations of dermatological pathologies on pre-existing wrists (oozing dermatosis, hyper sweating, eg.) or unhealed lesions on both wrists.
  • Presence of metallic object (bracelet, watch, piercing...) on both wrists.
  • Presence of a tattoo on both wrists
  • Allergic reactions on contact with silicone or metal
  • Persons referred to in Articles L 1121-5 to L 1121-8 of the CSP (corresponds to all protected persons) pregnant women, parturient women, nursing mothers, persons deprived of their liberty by judicial or administrative decision, persons subject to a legal protection measure
  • Women of childbearing age with a short-term pregnancy project

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

140 participants in 2 patient groups

Intervention
Experimental group
Description:
Millimetric wave emission bracelet.
Treatment:
Device: Wristband with millimeter wave emission.
Control
Sham Comparator group
Description:
Placebo bracelet.
Treatment:
Device: Placebo of wristband with millimeter wave emission.

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems